ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 33566 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 33566; 2) Community: the network communities that were significantly associated with the response to NSC 33566; 3) Molecule: the relationships between components within communities and NSC 33566; 4) MDR: the compounds that were significantly associated with the NSC 33566.

NSC Compound Enrichment Correlation
NSC 114346 Null 0.0285477013888565 0.19530451
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0285477013888565 0.06457289
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0285477013888565 0.32009754
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0285477013888565 0.056769831
NSC 18805 .gamma.-Thujaplicine 0.0285477013888565 0.11891535
NSC 303812 Aphidicoline glycinate 0.0285477013888565 -0.068650995
NSC 328784 1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide 0.0285477013888565 0.12689666
NSC 380856 ACRONYCINE, 2-NITRO 0.0285477013888569 0.15279754
NSC 606497 Camptothecin Derivative 0.0285477013888569 -0.18553187
NSC 615291 Bizelesin 0.0285477013888569 -0.20387708
Total:86  Current:57    [First] [Prev] [Next] [Last]